Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ADAPTiON: Apixaban Dose Adjustment in Patient With Thrombocytopenia in ONcology

NCT06886516 is registered in ClinicalTrials.gov with Rushad Patell as lead sponsor.

NCT NCT06886516
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06886516 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ADAPTiON: Apixaban Dose Adjustment in Patient With Thrombocytopenia in ONcology
Lead sponsor
Rushad Patell
Phase
Phase 1
Overall status
Recruiting
Start date
February 28, 2025
Completion date
July 1, 2029
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

deep vein thrombosis, pulmonary embolism and thrombosis, recurrent venous thromboembolism, thrombocytopenia